Key Takeaways
- Chinese artificial intelligence models collectively generate approximately 10% of the annual recurring revenue achieved by OpenAI and Anthropic
- OpenAI reports $40 billion in ARR while Anthropic reaches $65 billion
- ByteDance tops Chinese competitors with $4 billion ARR; DeepSeek generates $500 million
- Valuation multiples for Chinese AI startups reach extreme levels, with DeepSeek at 163x compared to OpenAI’s 34x
- Limited financing options and volatile equity markets may hamper Chinese AI laboratories’ expansion efforts
Chinese artificial intelligence enterprises are experiencing rapid expansion but continue to generate only a fraction of revenue compared to American competitors, based on fresh analysis from Rhodium Group.
The analysis reveals that China’s premier AI platforms collectively produce roughly 10% of the annual recurring revenue disclosed by OpenAI and Anthropic. This substantial disparity shows little indication of narrowing in the near term.
Rhodium’s assessment places OpenAI’s ARR at $40 billion and Anthropic’s at $65 billion. These figures significantly overshadow current revenue generation by Chinese companies.
ByteDance dominates among Chinese competitors with $4 billion in ARR, trailed by Alibaba at $2.4 billion. Z.ai, previously operating as Zhipu AI, disclosed to investors this week that its ARR has climbed to $1.8 billion.
Moonshot reported $1 billion, MiniMax achieved $800 million, while DeepSeek registered $500 million. Even when combined, these amounts remain considerably below OpenAI’s standalone performance.
Sky-High Valuations Despite Revenue Gap
Notwithstanding reduced revenue streams, Chinese AI ventures command elevated valuation multiples. Rhodium calculated DeepSeek’s valuation-to-revenue ratio at 163x and Moonshot’s at 50x.
In contrast, OpenAI stands at 34x while Anthropic registers 21x. Rhodium’s analysis characterized Moonshot and DeepSeek’s valuations as “exorbitant” when measured against present revenue generation.
These metrics indicate investors are wagering significantly on anticipated expansion that hasn’t yet materialized in financial performance.
Capital Access and Growth Obstacles
Logan Wright, a Rhodium Group partner who contributed to the research, indicated Chinese AI laboratories confront substantial financing obstacles moving forward.
“The financing gap means it will be far more difficult for Chinese frontier AI labs to scale sustainably,” Wright stated. He emphasized that government funding in China has predominantly targeted chips and servers rather than model developers.
Rhodium calculated that state-connected sources comprised over 60% of equity investment in Chinese AI semiconductor and hardware infrastructure.
Wright additionally observed these companies will depend extensively on equity markets, which have demonstrated historical volatility in China.
Information from Artificial Analysis indicates that leading US models from OpenAI and Anthropic remain predominantly closed-source and command higher per-task pricing than Chinese options. Chinese platforms have captured market share partially through competitive pricing strategies.
Multiple Chinese AI enterprises are currently pursuing public offerings. Moonshot has purportedly submitted confidential documentation for a Hong Kong IPO, while DeepSeek is also reportedly preparing for a listing.
Among American companies, Anthropic is anticipated to launch its public offering in October. OpenAI has allegedly delayed its listing timeline until next year.
Rhodium’s research presents an unambiguous assessment: Chinese AI organizations are expanding, yet the revenue differential with US industry leaders remains substantial, and the trajectory for narrowing this gap remains ambiguous.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
